New York Mets pitcher David Peterson is projected to miss the start of next season following surgery to repair a torn labrum in left hip

The King visits "Korea Town" in New Malden, which claims to have Europe's biggest Korean population.

Sporting Kansas City defender Logan Ndenbe tore the ACL in his right knee in the club’s win over St. Louis City last weekend, sidelining him for the rest of the MLS Cup playoffs and into next season

John Stones’ injury has given England manager Gareth Southgate the chance to explore his centre-back options in the Euro 2024 qualifiers against Malta and North Macedonia. The City defender was forced off with a problem in Tuesday’s Champions League win over Young Boys with boss Pep Guardiola admitting it is “deep bad news”. Stones only returned to action in October after a two-month absence with hamstring and hip problems but Southgate had no hesitation in starting him in the important qualifying win over Italy. But with qualification for the summer’s tournament in Germany already secured, Southgate – who names his squad on Thursday – can afford to look at his back-up options. Brighton captain Lewis Dunk and AC Milan’s Fikayo Tomori started together in last month’s friendly win over Australia but Crystal Palace’s Marc Guehi was the man Southgate opted to replace Stones for the final 27 minutes against Italy and has the most caps of the trio. Injuries to Ben Chilwell and Luke Shaw meant Kieran Trippier filled in at left-back against Italy but Chelsea’s Levi Colwill started against Australia and could be another one to benefit from any experimentation. Colwill’s club captain Reece James could be in for a recall having returned from injury while Chelsea team-mate Raheem Sterling will be hoping two goals and some improved form in his last five matches will earn him a call-up for the first time since the World Cup. Those chances could be enhanced depending on the extent of the ankle injury sustained by James Maddison during Tottenham’s loss to Chelsea on Monday and how significant the hamstring problem which forced off Callum Wilson in Newcastle’s Champions League defeat against Borussia Dortmund. But Arsenal forward Bukayo Saka should return after withdrawing from the squad in October. Manchester City midfielder Kalvin Phillips’ 49 minutes of action since his international start against Italy is unlikely to count against him, but James Ward-Prowse is knocking on the door of a first call-up in 14 months after a number of good performances for West Ham. Read More Jos Buttler wants to remain as England one-day captain despite poor World Cup Lauren Williams opens up on challenging time coping with Tokyo heartbreak Michael O’Neill expecting a tough international window for Northern Ireland

WASHINGTON (Reuters) -The U.S. Justice Department will launch a civil rights probe of Lexington, Mississippi, and its police department after

Over three weeks since their quarter-final exit at the hands of South Africa, France coach Fabien Galthie finally opened up on Wednesday about the "scar that will...

The Houston Astros will likely be losing three key relievers this winter in free agency. Here are three free agent relievers that could be of use to them.

Lalibela is home to famous 13th Century churches that are registered as Unesco world heritage sites.

Elon Musk's chip implant company Neuralink is looking for its first volunteer since the company got approved to perform tests on humans by the FDA. Prior to its approval for human clinical trials, Reuters reported that the company had killed roughly 1,500 animals during testing. The volunteer would have to be willing to have a piece of their skull removed so a robotic surgeon can insert thin wires and electrodes into their brain. The company told Bloomberg News, the ideal candidate will be a quadriplegic under the age of 40. Neuralink hopes to eventually make a device that will allow people to send messages or play games using only their thoughts. Ashlee Vance, the author of the 2015 biography 'Elon Musk: Tesla, SpaceX, and the Quest for a Fantastic Future', said in his Bloomberg report that despite "an outpouring of interest from thousands of prospective patients," the company is still seeking its first volunteer. The chip would enable computer functions to be performed using only thoughts via a "think-and-click" mechanism. If the ideal volunteer is chosen, a surgeon will remove part of the person's skull, before a robot dubbed "R1", equipped with cameras, sensors and a needle will push 64 threads into the brain whilst doing its best to avoid blood vessels. Reassuring. Each thread has roughly the diameter of 1/14th of a strand of human hair, and is lined with 16 electrodes that are programmed to gather data about the brain. The electrodes record neural activity related to movement intention, which is then decoded by Neuralink computers. Neuralink did not reveal how many participants would be enrolled in the trial or how many patients the FDA ultimately approved, after a negotiation between the company and agency which raised safety concerns, according to current and former employees. DJ Seo, co-founder and vice president for engineering of Neuralink told Bloomberg: "The short-term goal of the company is to build a generalised brain interface and restore autonomy to those with debilitating neurological conditions and unmet medical needs." "Then, really, the long-term goal is to have this available for billions of people and unlock human potential and go beyond our biological capabilities." Indy100 has reached out to Neuralink for comment. Sign up to our free Indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings. How to join the indy100's free WhatsApp channel

Barcelona defender Ronald Araujo has undergone scans on a suspected thigh injury suffered during Tuesday night's Champions League defeat to Shakhtar Donetsk.

Australia’s prime minister is likely to face some pointed questions over climate action and a nuclear submarine deal

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug